Detalhe da pesquisa
1.
Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursement.
Int J Technol Assess Health Care
; 39(1): e20, 2023 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37039100
2.
Pre-approval and post-approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs.
Br J Clin Pharmacol
; 88(5): 2169-2179, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34779004
3.
Key Considerations in the Health Technology Assessment of Advanced Therapy Medicinal Products in Scotland, The Netherlands, and England.
Value Health
; 25(3): 390-399, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35227451
4.
Impact of medicine shortages on patients - a framework and application in the Netherlands.
BMC Health Serv Res
; 22(1): 1366, 2022 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36397073
5.
Addressing uncertainty in relative effectiveness assessments by HTA organizations.
Int J Technol Assess Health Care
; 38(1): e17, 2022 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094740
6.
Estimation of manufacturing development costs of cell-based therapies: a feasibility study.
Cytotherapy
; 23(8): 730-739, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33593688
7.
Early Cost-Effectiveness of Onasemnogene Abeparvovec-xioi (Zolgensma) and Nusinersen (Spinraza) Treatment for Spinal Muscular Atrophy I in The Netherlands With Relapse Scenarios.
Value Health
; 24(6): 759-769, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34119073
8.
Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries.
Cytotherapy
; 22(10): 592-600, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32563611
9.
What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings.
Cytotherapy
; 22(7): 388-397, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414635
10.
Efficacy gap between phase II and subsequent phase III studies in oncology.
Br J Clin Pharmacol
; 86(7): 1306-1313, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32034790
11.
A Review of Methodological Considerations for Economic Evaluations of Gene Therapies and Their Application in Literature.
Value Health
; 23(9): 1268-1280, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32940245
12.
Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice Variations.
Value Health
; 23(1): 10-16, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31952664
13.
Prescribing patterns and compliance with World Health Organization recommendations for the management of severe malaria: a modified cohort event monitoring study in public health facilities in Ghana and Uganda.
Malar J
; 18(1): 36, 2019 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30736864
14.
Post-marketing dosing changes in the label of biologicals.
Br J Clin Pharmacol
; 85(4): 715-721, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30593087
15.
Unmet Medical Need: An Introduction to Definitions and Stakeholder Perceptions.
Value Health
; 22(11): 1275-1282, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31708064
16.
The accuracy of date of death recording in the Clinical Practice Research Datalink GOLD database in England compared with the Office for National Statistics death registrations.
Pharmacoepidemiol Drug Saf
; 28(5): 563-569, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30908785
17.
Potentially inappropriate medications with risk of cardiovascular adverse events in the elderly: A systematic review of tools addressing inappropriate prescribing.
J Clin Pharm Ther
; 44(3): 349-360, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30746726
18.
Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations.
Diabetes Obes Metab
; 20 Suppl 3: 19-23, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30294953
19.
Comparing safety information of biosimilars with their originators: a cross-sectional analysis of European risk management plans.
Br J Clin Pharmacol
; 84(4): 738-763, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29164665
20.
Increased risk of all-cause mortality associated with domperidone use in Parkinson's patients: a population-based cohort study in the UK.
Br J Clin Pharmacol
; 84(11): 2551-2561, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29975795